HEKA Vision, led by researchers from the Champalimaud Foundation (Portugal), is one of the supported research teams in the first S3E Start Programme.
HEKA Vision’s technological platform integrates Artificial Intelligence (AI) and eXtended Reality (XR) to revolutionise breast cancer surgery. Their cutting-edge solutions overcome current workflow inefficiencies that result in unnecessary invasive preoperative procedures and often lead to suboptimal treatment outcomes, such as high mastectomy and re-operation rates.
HEKA Vision’s advanced AI tools provide surgeons with real-time insights, empowering them to make more informed decisions, and facilitating personalised treatment plans during the whole treatment workflow: from medical imaging analysis all the way into the operating room during surgery. Through its XR technologies, surgeons can visualise and interact with patient-specific data in a digitally augmented environment, improving precision and reducing risks.
With BreastXR, surgeons will visualise the tumour in real-time during breast conserving surgery. AvaXR will allow precise visualisation of the abdominal vascular network during the challenging DIEAP procedure for breast reconstructive surgery. These technologies not only streamline surgical workflows but also enable quicker and more accurate surgeries. Overall, HEKA Vision’s technologies set a new standard for breast cancer treatment. They greatly increase the overall efficiency of breast cancer surgery, leading to higher productivity for the medical staff and cancer clinics, while improving patient outcomes and their quality of life.
Learn more about HEKA Vision by watching the pitch done by researcher João Santinha during the Start Open Day on 20th July 2023.
Would you like to get in touch with them? Let us know! Email us at info@south3e.eu